We are live on ! Find out more
B

Bailard Portfolio holdings

AUM $4.35B
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
-4.61%
1 Year Est. Return
+23.57%
3 Year Est. Return
+74.84%
5 Year Est. Return
+96.64%
10 Year Est. Return
+374.16%
AUM
$2.42B
AUM Growth
-$122M
Cap. Flow
+$14.9M
Cap. Flow %
0.62%
Top 10 Hldgs %
32.13%
Holding
794
New
116
Increased
220
Reduced
211
Closed
134
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVEO
626
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$125K 0.01%
+15,200
New +$117K
ORIC icon
627
Oric Pharmaceuticals
ORIC
$1.13B
$123K 0.01%
+38,505
New +$154K
HLX icon
628
Helix Energy Solutions
HLX
$1.43B
$122K 0.01%
+31,700
New +$120K
LENZ
629
LENZ Therapeutics
LENZ
$158M
$99K ﹤0.01%
+4,471
New +$107K
TTSH
630
DELISTED
Tile Shop Holdings
TTSH
$94K ﹤0.01%
+26,702
New +$95.7K
BRLT icon
631
Brilliant Earth
BRLT
$18.2M
$93K ﹤0.01%
+16,300
New +$105K
TDUP icon
632
ThredUp
TDUP
$741M
$93K ﹤0.01%
+50,667
New +$127K
LYTS icon
633
LSI Industries
LYTS
$860M
$92K ﹤0.01%
12,000
+2,000
+20% +$13.9K
HOWL icon
634
Werewolf Therapeutics
HOWL
$17.5M
$91K ﹤0.01%
20,200
-1,000
-5% -$5.43K
XERS icon
635
Xeris Biopharma Holdings
XERS
$1.45B
$87K ﹤0.01%
+56,000
New +$92.6K
AKLI
636
DELISTED
Akili Inc
AKLI
$87K ﹤0.01%
+38,357
New +$275K
IHRT icon
637
iHeartMedia
IHRT
$552M
$86K ﹤0.01%
+11,700
New +$101K
NHS
638
Neuberger High Yield Strategies Fund Inc
NHS
$251M
$86K ﹤0.01%
10,839
RNAC icon
639
Cartesian Therapeutics
RNAC
$233M
$86K ﹤0.01%
1,740
+73
+4% +$4.01K
BBCP icon
640
Concrete Pumping Holdings
BBCP
$550M
$85K ﹤0.01%
+13,211
New +$88.7K
GNW icon
641
Genworth Financial
GNW
$3.8B
$84K ﹤0.01%
+23,900
New +$96.4K
WTTR icon
642
Select Water Solutions
WTTR
$2.59B
$84K ﹤0.01%
+12,000
New +$83.2K
CLNE icon
643
Clean Energy Fuels
CLNE
$460M
$81K ﹤0.01%
+15,200
New +$95.2K
ASRT
644
DELISTED
Assertio
ASRT
$80K ﹤0.01%
2,353
+240
+11% +$10.8K
EVC icon
645
Entravision Communication
EVC
$969M
$79K ﹤0.01%
19,800
-18,900
-49% -$93.6K
ACCO icon
646
Acco Brands
ACCO
$362M
$78K ﹤0.01%
+15,900
New +$101K
BOLT icon
647
Bolt Biotherapeutics
BOLT
$7.32M
$69K ﹤0.01%
+2,319
New +$96K
HLN icon
648
Haleon
HLN
$42.8B
$69K ﹤0.01%
+11,318
New +$73.3K
ESOA icon
649
Energy Services of America
ESOA
$312M
$67K ﹤0.01%
+23,300
New +$61.3K
HGBL icon
650
Heritage Global
HGBL
$41.7M
$51K ﹤0.01%
+31,718
New +$52.8K

Similar funds

Bailard's Q3 2022 Portfolio in Review

As of Q3 2022, Bailard held 794 positions worth $2.42B, down 4.8% from $2.54B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bailard's Q3 2022 filing shows 116 new, 220 increased, 211 reduced and 134 closed positions. Its largest new stake was iShares ESG Screened S&P Mid-Cap ETF: 141,107 shares worth $4.2M. The largest sale was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $69.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bailard's largest Q3 2022 buy was iShares ESG Screened S&P Mid-Cap ETF: 141,107 shares worth $4.2M.
  • Bailard added most to iShares 1-3 Year Treasury Bond ETF in Q3 2022, an estimated $70.6M increase.
  • Bailard's biggest Q3 2022 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $69.2M.
  • Bailard fully exited First Trust Senior Loan Fund ETF in Q3 2022, selling an estimated $15.1M.
  • Bailard's ten largest holdings make up 32% of its $2.42B portfolio in Q3 2022.
  • Bailard opened 116 new positions and closed 134 in Q3 2022.
  • Bailard's portfolio value fell 4.8% quarter-over-quarter to $2.42B.

Based on Bailard's 13F filing for Q3 2022, filed 18 Oct 2022.